Kagocel Tablets for colds and flu, 12 mg , 10 pcs

Dosage form

pills

Manufacturer

Nearmedic Pharma, Russia

Structure

1 tab .:

Kagocel 12 mg

Excipients: potato starch - 10 mg, calcium stearate - 0.65 mg, ludipress (direct compression lactose with the composition: lactose monohydrate, povidone (Kollidon 30), crospovidone (Kollidon CL)) - until a tablet weighing 100 mg is obtained.

pharmachologic effect

The main mechanism of action of Kagocel is the ability to induce the production of interferon.

Kagocel causes the formation of the so-called late interferon in the human body, which is a mixture?

and?

interferons with high antiviral activity.

Kagocel causes the production of interferon in almost all populations of cells involved in the antiviral response of the body: T- and B-lymphocytes, macrophages, granulocytes, fibroblasts, endothelial cells.

When a single dose of Kagocel is taken orally, the interferon titer in the blood serum reaches its maximum values ​​after 48 hours.

The body's interferon response to the introduction of Kagocel is characterized by prolonged (up to 4-5 days) circulation of interferon in the bloodstream.

The dynamics of the accumulation of interferon in the intestine when ingested Kagocel does not coincide with the dynamics of the titers of circulating interferon.

In the blood serum, the production of interferon reaches high values ​​only 48 hours after taking Kagocel, while in the intestine the maximum production of interferon is noted already after 4 hours.

Kagocel, when administered in therapeutic doses, is non-toxic, does not accumulate in the body.

The drug does not possess mutagenic and teratogenic properties, is not carcinogenic and does not have an embryotoxic effect.

Indications

Kagocel is used in adults as a prophylactic and therapeutic agent for influenza and other acute respiratory viral infections (ARVI), as well as a therapeutic agent for herpes.

Kagocel is used in children aged 6 and over as a prophylactic agent for influenza and other acute respiratory viral infections.

Kagocel is used in children aged 3 years and older as a remedy for influenza and other acute respiratory viral infections.

Contraindications

Individual hypersensitivity, pregnancy, age up to 3 years, lactase deficiency, lactose intolerance, glucose-galactose malabsorption.

Side effects

The development of allergic reactions is possible.

Interaction

Kagocel combines well with other antiviral drugs, immunomodulators and antibiotics (additive effect).

How to take, course and dosage

For oral administration.

For the treatment of influenza and acute respiratory viral infections, adults are prescribed in the first two days - 2 tablets of Kagocel 3 times a day, in the next two days - one tablet 3 times a day.

In total, the course - 18 tablets, course duration - 4 days.

Prevention of influenza and ARVI in adults is carried out in 7-day cycles: two days - 2 tablets once a day, a break for 5 days, then repeat the cycle.

The duration of the preventive course is from one week to several months.

For the treatment of herpes in adults, 2 tablets are prescribed 3 times a day for 5 days.

In total, the course - 30 tablets, the duration of the course - 5 days.

For the treatment of influenza and ARVI, children aged 3 to 6 years are prescribed in the first two days - 1 tablet of Kagocel 2 times a day, in the next two days - one tablet 1 time a day.

A total of 6 tablets for the course, the duration of the course is 4 days.

For the treatment of influenza and acute respiratory viral infections, children aged 6 years and older are prescribed in the first two days - 1 tablet 3 times a day, in the next two days - one tablet 2 times a day.

In total for the course - 10 tablets, the duration of the course - 4 days.

Prevention of influenza and ARVI in children aged 6 years and older is carried out in 7-day cycles: two days - 1 tablet of Kagocel 1 time per day, a break for 5 days, then repeat the cycle.

The duration of the preventive course is from one week to several months.

Overdose

In case of an accidental overdose, it is recommended to prescribe an abundant drink, induce vomiting.

Special instructions

To achieve a therapeutic effect, Kagocel® should be taken no later than the fourth day from the onset of the disease.

Release form

Tablets, round, biconvex, cream-colored, interspersed.

Storage conditions

In a dry, dark place at a temperature not exceeding 25 ° C

Shelf life

2 years

Brand name

KAGOCEL

Terms of dispensing from pharmacies

Without recipe

Name ENG

KAGOCEL

Clinical and pharmacological group

Antiviral drug, inducer of interferon synthesis.

ATX code

Other antiviral drugs.

Dosage

12 mg

Structure

1 tablet: Kagocel 12 mg. Excipients: potato starch - 10 mg, calcium stearate - 0.65 mg, ludipress (direct compression lactose with the composition: lactose monohydrate, povidone (Kollidon 30), crospovidone (Kollidon CL)) - until a tablet weighing 100 mg.

Indications

prevention and treatment of influenza and other acute respiratory viral infections in adults

treatment of influenza and other acute respiratory viral infections in children 3 years of age and older

treatment of herpes in adults.

Storage conditions and periods

Store in a dry, dark place at a temperature not exceeding 25 ° C.

Shelf life 2 years.

INN / Active ingredient

Kagocel

Contraindications

pregnancy

children under 3 years old

increased individual sensitivity

Specifications

Category

Antiviral

,

Antimicrobial agents

Scope of the medicinal product

General

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

ten

Scope of application

Virology

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Nearmedic Pharma LLC

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Antiviral agent

Anatomical and therapeutic characteristics

J05AX Other antiviral drugs

Dosage form

Pills

Dosage (volume) of the substance in the preparation

12 mg

Expiration date in days

1460

The target audience

Children

Package weight, g

ten

Mode of application

:

For oral administration. For the treatment of influenza and ARVI, adults are prescribed in the first two days - 2 tablets of Kagocel 3 times a day, in the next two days - one tablet 3 times a day. In total for the course - 18 tablets, the duration of the course - 4 days. < br> Prevention of influenza and ARVI in adults is carried out in 7-day cycles: two days - 2 tablets once a day, 5 days break, then repeat the cycle. The duration of the preventive course is from one week to several months. < br> For the treatment of herpes in adults, 2 tablets are prescribed 3 times a day for 5 days. In total for the course - 30 tablets, the duration of the course - 5 days. < br> For the treatment of influenza and ARVI, children aged 3 to 6 years are prescribed in the first two days - 1 tablet of Kagocel 2 times a day, in the next two days - on one tablet once a day. In total for the course - 6 tablets,course duration - 4 days. < br> For the treatment of influenza and ARVI, children aged 6 years and older are prescribed in the first two days - 1 tablet 3 times a day, in the next two days - one tablet 2 times a day. In total for the course - 10 tablets, course duration - 4 days. < br> Prevention of influenza and ARVI in children aged 6 years and older is carried out in 7-day cycles: two days - 1 tablet of Kagocel 1 time per day, 5 days break, then repeat the cycle. The duration of the preventive course is from one week to several months.Prevention of influenza and ARVI in children aged 6 years and older is carried out in 7-day cycles: two days - 1 tablet of Kagocel 1 time per day, a break for 5 days, then repeat the cycle. The duration of the preventive course is from one week to several months.Prevention of influenza and ARVI in children aged 6 years and older is carried out in 7-day cycles: two days - 1 tablet of Kagocel 1 time per day, a break for 5 days, then repeat the cycle. The duration of the preventive course is from one week to several months.

Information on technical characteristics, delivery set, country of manufacture